Literature DB >> 7911115

Gastrin and somatostatin in Helicobacter pylori infected antral mucosa.

L Odum1, H D Petersen, I B Andersen, B F Hansen, J F Rehfeld.   

Abstract

Helicobacter pylori infection is associated with increased meal stimulated gastrin secretion, but the reason for this is unknown. Sequence specific radioimmunoassays were used to measure the concentration of alpha-amidated gastrin, the total progastrin product, and somatostatin in biopsy specimens of human antral mucosa. The antral concentrations of alpha-amidated gastrin and of total progastrin products were significantly higher in H pylori infected patients than in those not infected by this organism. In contrast, the antral somatostatin concentration was significantly decreased in infected patients. Progastrin processing, determined by gel chromatography, seemed unaffected by H pylori infection. The results suggest that the finding of increased gastrin secretion from the antral G cells in H pylori infected patients may be a result of reduced inhibition of G-cell secretion by somatostatin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7911115      PMCID: PMC1374743          DOI: 10.1136/gut.35.5.615

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  25 in total

1.  Reciprocal regulation of antral gastrin and somatostatin gene expression by omeprazole-induced achlorhydria.

Authors:  S J Brand; D Stone
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

Review 2.  The reliability of urease tests, histology and culture in the diagnosis of Campylobacter pylori infection.

Authors:  M Deltenre; Y Glupczynski; C De Prez; J F Nyst; A Burette; M Labbé; C Jonas; E DeKoster
Journal:  Scand J Gastroenterol Suppl       Date:  1989

3.  Production and evaluation of antibodies for the radioimmunoassay of gastrin.

Authors:  J F Rehfeld; F Stadil; B Rubin
Journal:  Scand J Clin Lab Invest       Date:  1972-10       Impact factor: 1.713

4.  Regulation of the gastrin promoter by epidermal growth factor and neuropeptides.

Authors:  J M Godley; S J Brand
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

5.  On the accuracy of radioimmunological determination of somatostatin in plasma.

Authors:  L Hilsted; J J Holst
Journal:  Regul Pept       Date:  1982-06

6.  Impaired alpha-carboxyamidation of gastrin in vitamin C-deficient guinea pigs.

Authors:  L Hilsted; J F Rehfeld; T W Schwartz
Journal:  FEBS Lett       Date:  1986-02-03       Impact factor: 4.124

7.  Ascorbic acid: a factor concentrated in human gastric juice.

Authors:  B J Rathbone; A W Johnson; J I Wyatt; J Kelleher; R V Heatley; M S Losowsky
Journal:  Clin Sci (Lond)       Date:  1989-03       Impact factor: 6.124

8.  Progastrin processing during antral G-cell hypersecretion in humans.

Authors:  S Jensen; K Borch; L Hilsted; J F Rehfeld
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682

9.  Effect of Helicobacter pylori on parietal cell sensitivity to pentagastrin in duodenal ulcer subjects.

Authors:  R S Chittajallu; C A Howie; K E McColl
Journal:  Scand J Gastroenterol       Date:  1992-10       Impact factor: 2.423

10.  Detection of Campylobacter pylori by the biopsy urease test: an assessment in 1445 patients.

Authors:  C A McNulty; J C Dent; J S Uff; M W Gear; S P Wilkinson
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

View more
  18 in total

1.  Inhibitory potency of twice-a-day omeprazole on gastric acidity is enhanced by eradication of H. pylori in duodenal ulcer patients.

Authors:  A B R Thomson; M Keelan; R Lastiwka; S Appelman-Eszczuk; L Zuk; L Drozdowski; A Prentice; P Sinclair
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

2.  Gastrin and antral G cells in course of Helicobacter pylori eradication: six months follow up study.

Authors:  Aleksandra Sokic-Milutinovic; Vera Todorovic; Tomica Milosavljevic; Marjan Micev; Neda Drndarevic; Olivera Mitrovic
Journal:  World J Gastroenterol       Date:  2005-07-21       Impact factor: 5.742

3.  Expression of progastrin-derived peptides and somatostatin in fundus and antrum of nonulcer dyspepsia subjects with and without Helicobacter pylori infection.

Authors:  Y Zavros; A Paterson; J Lambert; A Shulkes
Journal:  Dig Dis Sci       Date:  2000-10       Impact factor: 3.199

4.  Gastrin (G) cells and somatostatin (D) cells in patients with dyspeptic symptoms: Helicobacter pylori associated and non-associated gastritis.

Authors:  Y Liu; G D C Vosmaer; G N J Tytgat; S-D Xiao; F J W Ten Kate
Journal:  J Clin Pathol       Date:  2005-09       Impact factor: 3.411

5.  Eradicating Helicobacter pylori reduces hypergastrinaemia during long-term omeprazole treatment.

Authors:  A el-Nujumi; C Williams; J E Ardill; K Oien; K E McColl
Journal:  Gut       Date:  1998-02       Impact factor: 23.059

6.  A morphometric study of antral G-cell density in a sample of adult general population: comparison of three different methods and correlation with patient demography, helicobacter pylori infection, histomorphology and circulating gastrin levels.

Authors:  Fredrik Petersson; Kurt Borch; Jens F Rehfeld; Lennart E Franzén
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

7.  Treatment of Helicobacter gastritis with IL-4 requires somatostatin.

Authors:  Yana Zavros; Sivaprakash Rathinavelu; John Y Kao; Andrea Todisco; John Del Valle; Joel V Weinstock; Malcolm J Low; Juanita L Merchant
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-10       Impact factor: 11.205

Review 8.  Helicobacter pylori infection in functional dyspepsia.

Authors:  Hidekazu Suzuki; Paul Moayyedi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-01-29       Impact factor: 46.802

Review 9.  Different management for Helicobacter pylori positive and negative patients with gastro-oesophageal reflux disease?

Authors:  J M Lee; C A O'Morain
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

Review 10.  Gastrin and the Moderate Hypergastrinemias.

Authors:  Jens F Rehfeld
Journal:  Int J Mol Sci       Date:  2021-06-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.